P030019S002

None

FDA Premarket Approval P030019 S002

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP030019S002
Classification NameNone
Applicant
PMAP030019
SupplementS002

Supplemental Filings

Supplement NumberDateSupplement Type
P030019Original Filing
S027 2022-10-12 30-day Notice
S026 2020-12-30 135 Review Track For 30-day Notice
S025 2020-11-09 30-day Notice
S024
S023 2016-02-10 Special (immediate Track)
S022 2014-12-24 135 Review Track For 30-day Notice
S021 2014-06-25 30-day Notice
S020 2014-06-10 30-day Notice
S019 2014-05-15 30-day Notice
S018 2011-08-24 135 Review Track For 30-day Notice
S017 2010-11-03 135 Review Track For 30-day Notice
S016
S015 2010-06-09 30-day Notice
S014 2009-06-16 Normal 180 Day Track No User Fee
S013 2006-07-24 135 Review Track For 30-day Notice
S012 2006-08-09 Normal 180 Day Track
S011
S010 2006-07-10 30-day Notice
S009 2006-04-28 Normal 180 Day Track
S008 2006-01-03 30-day Notice
S007
S006 2004-07-01 Normal 180 Day Track
S005 2004-06-17 30-day Notice
S004 2004-05-07 30-day Notice
S003 2004-03-16 30-day Notice
S002
S001 2004-02-27 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
05060548950026 P030019 000
08437027710025 P030019 000
05060459970038 P030019 022
00817337000111 P030019 026

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.